Physician profile
Mark D Wagner
NPI 1649211764
$1,579.85
in general payments reported to CMS, 2019-2025
19 companies · $140 in 2025
The $140 reported for 2025 was more than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $323 · 2020: $508 · 2021: $130 · 2022: $94.09 · 2023: $147 · 2024: $237 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $524.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $394.84 | 2019-2022 | |
| Antares Pharma, INC. | $215.72 | 2024-2025 | Xyosted |
| Amarin Pharma, INC. | $211.77 | 2020-2021 | |
| Pfizer INC. | $177.43 | 2019-2021 | |
| Novo Nordisk INC | $138.68 | 2020-2025 | Wegovy, Rybelsus, Ozempic |
| Fidia Pharma USA INC. | $77.15 | 2019-2020 | |
| Bioventus LLC | $47.45 | 2021 | |
| Hydrocision, INC. | $43.86 | 2019 | |
| Abbvie INC. | $42.67 | 2025 | |
| Halozyme INC | $35.38 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $32.61 | 2022 | |
| Hologic Sales and Service, LLC | $32.34 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.00 | 2025 | Jardiance |
| Exact Sciences Corporation | $18.86 | 2025 | The Cologuard Plus Collection Kit |
| Depuy Synthes Sales INC. | $17.62 | 2023 | Monovisc |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $17.52 | 2023 | Euflexxa |
| Zimmer Biomet Holdings, INC. | $17.15 | 2024 | Gel-One Cross-Linked Hyaluronate |
| Avanos Medical | $17.11 | 2023 | Trivisc Sodium Hyaluronate |
| Lilly USA, LLC | $15.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Wagner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.